Stradling files S-1 for San Diego-based Tandem Diabetes Care, Inc. It plans to list on the Nasdaq under ticker symbol TNDM.
The Stradling team was led by shareholder Bruce Feuchter. Read the article, or the official press release.
This is Stradling's second S-1 filing for a San Diego-based company in a week. Read about the filing for Biocept Laboratories, Inc. here.